CHIP-AML22 Master protocol: An open label complex clinical trial in newly diagnosed pediatric de novo AML patients – a study by the NOPHO-DB-SHIP consortium Master Protocol.
Datos básicos
Documentos
- No hay documentos
Grupos
Financiadores - Promotores
PRINCESS MÁXIMA CENTER FOR PEDIATRIC ONCOLOGY B.V.,
Portal de investigación